Overview
RXRX market data
Price History
RXRX price chart · 1M
- O
- 3.52
- H
- 3.55
- L
- 3.42
- C
- 3.44
- Vol
- 449,659.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $3.52
- Previous Close
- $3.48
- Day High
- $3.55
- Day Low
- $3.42
- 52 Week High
- $4.09
- 52 Week Low
- $2.77
- 7 Day Return
- +3.00%
- 30 Day Return
- +12.62%
- 90 Day Return
- -3.92%
- 1 Year Return
- +3.78%
- Daily Notional Volume
- $1.5M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.44 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.10 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -945.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.77 – $7.18 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.8B · P/B 1.88 · P/S 32.36.
Company News
AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma PlayersGlobenewswire Inc · Aug 25, 2026, 5:15 PM
Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's WhyBenzinga · Aug 20, 2026, 11:25 AM
Jim Cramer: These Utilities Stocks Are 'Oversold,' Fastly 'Back From The Abyss'Benzinga · Aug 13, 2026, 12:00 PM
AI Disruption Reshapes Bioinformatics: Record Investment and Breakthrough Tools Signal a New Era for Drug Discovery and Precision MedicineGlobenewswire Inc · Aug 6, 2026, 3:15 PM
Recursion Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga · Aug 5, 2026, 1:07 PM
8-K filing — RECURSION PHARMACEUTICALS, INC. (RXRX)SEC EDGAR · Aug 5, 2026, 10:31 AM
Recursion Pharmaceuticals Q2 EPS $(0.25) Misses $(0.22) Estimate, Sales $7.670M Miss $11.947M EstimateBenzinga · Aug 5, 2026, 10:31 AM
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing RulesGlobenewswire Inc · Jul 31, 2026, 9:31 PM
Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and DevelopmentGlobenewswire Inc · Jul 10, 2026, 3:15 PM
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?The Motley Fool · Jul 3, 2026, 4:15 PM